| 2024-02-07 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 8,037 0.0074% | $950.35 | $7.64M | +2.96% | |
| 2023-08-22 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 11,665 0.0108% | $840.98 | $9.81M | +7.76% | |
| 2022-08-04 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 100 <0.0001% | $621.11 | $62,111 | +20.35% | |
| 2021-05-17 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 17,521 0.0166% | $519.46 | $9.1M | +18.8% | |
| 2020-05-11 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 5,305 0.0048% | $569.52 | $3.02M | -3.73% | |
| 2020-04-14 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 5,497 0.005% | $521.07 | $2.86M | +6.44% | |
| 2020-02-27 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 10,349 0.0099% | $452.26 | $4.68M | +29.43% | |
| 2020-02-13 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 10,278 0.0094% | $400.66 | $4.12M | +40.08% | |
| 2019-11-26 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 4,006 0.0037% | $364.07 | $1.46M | +53.55% | |
| 2019-11-08 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 7,364 0.0067% | $338.52 | $2.49M | +63.02% | |
| 2019-05-14 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 9,853 0.0091% | $305.74 | $3.01M | +11.09% | |
| 2018-05-24 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 11,407 0.0106% | $295.09 | $3.37M | +27.46% | |
| 2017-06-22 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 8,306 0.0079% | $532.55 | $4.42M | -27.5% | |
| 2017-06-15 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 8,567 0.0081% | $468.45 | $4.01M | -18.44% | |
| 2017-06-02 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 2,812 0.0026% | $479.49 | $1.35M | -19.84% | |
| 2015-11-09 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 22,101 0.0215% | $560.05 | $12.38M | -28.57% | |
| 2015-11-06 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research and Development | 20,000 0.0194% | $563.00 | $11.26M | -28.94% | |
| 2014-11-24 | Sale | Regeneron Pharmaceuticals, Inc. REGN | SVP Research and Development S | 2,200 0.0022% | $409.78 | $901,523 | +19.81% | |
| 2014-11-21 | Sale | Regeneron Pharmaceuticals, Inc. REGN | SVP Research and Development S | 3,107 0.0032% | $415.16 | $1.29M | +20.67% | |
| 2014-08-11 | Sale | Regeneron Pharmaceuticals, Inc. REGN | SVP Research and Development S | 11,646 0.0116% | $339.96 | $3.96M | +24.31% |